108 related articles for article (PubMed ID: 10096106)
1. [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
Yamanishi A; Ishibashi Y; Kuriyama K; Tachiiri T; Kusajima H; Kojima E; Momo K
Nihon Yakurigaku Zasshi; 1999 Jan; 113(1):55-65. PubMed ID: 10096106
[TBL] [Abstract][Full Text] [Related]
2. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
Xia W; Meng X; Xing X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):702-5. PubMed ID: 11798840
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol.
Khajuria DK; Razdan R; Mahapatra DR; Bhat MR
J Orthop Sci; 2013 Sep; 18(5):832-42. PubMed ID: 23835529
[TBL] [Abstract][Full Text] [Related]
5. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
[TBL] [Abstract][Full Text] [Related]
6. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
7. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin-induced bone loss and its prevention with alfacalcidol or calcitriol in growing rats.
Onodera K; Takahashi A; Mayanagi H; Wakabayashi H; Kamei J; Shinoda H
Calcif Tissue Int; 2001 Aug; 69(2):109-16. PubMed ID: 11683423
[TBL] [Abstract][Full Text] [Related]
9. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
Nishii Y
J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
12. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
Moe S; Wazny LD; Martin JE
Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
[TBL] [Abstract][Full Text] [Related]
13. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
Erben RG; Bromm S; Stangassinger M
Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
[TBL] [Abstract][Full Text] [Related]
14. [Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol].
Galeşanu C; Ciubotariu C; Melnic G; Galeşanu MR
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):833-41. PubMed ID: 17438884
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
[TBL] [Abstract][Full Text] [Related]
16. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
[TBL] [Abstract][Full Text] [Related]
17. Ovariectomized murine model of postmenopausal calcium malabsorption.
Kalu DN; Chen C
J Bone Miner Res; 1999 Apr; 14(4):593-601. PubMed ID: 10234581
[TBL] [Abstract][Full Text] [Related]
18. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
[TBL] [Abstract][Full Text] [Related]
19. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
Kubodera N; Tsuji N; Uchiyama Y; Endo K
J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
[TBL] [Abstract][Full Text] [Related]
20. [Effect of total flavones of Epimedium leptorrhizum on osteoporosis in ovariectomized rats].
Cao CY; Liu T; Hui LQ; Hao R
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1913-7. PubMed ID: 25282905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
